Data Snapshot: Aug 04, 2026
$500K+

Jul-2026

Sales

Growth

Trend

6-Month

58

Product Count

SKUs

$17.81

Avg Price

1.3%

YoY Sales Change

0%

YoY Price Change

Mr. Moxey's, a trailblazer in the therapeutic cannabis field, stands out for its innovative combination of traditional herbs and modern CBD research to naturally enhance well-being. As the creator of the country's leading low-dose edible and widely acclaimed CBD infused products, the brand has successfully reshaped expectations for cannabis edibles. With a focus on integrating specific herbal blends with cannabis or hemp to affect mood states, and strategic partnerships facilitating product expansion, this adults-only brand is rapidly gaining national recognition.
Mr. Moxey's

Where to Buy

Mr. Moxey's is stocked at 417 licensed dispensaries across Washington, Oregon, and 2 other states, 175 of them in Washington, with the deepest coverage in Seattle, Olympia, Tacoma, Bellingham, and Everett. Search by ZIP code or city below to find the closest one.

https://headsetstorage.blob.core.windows.net/brand-stores/334.json?v=20260804
Mr. Moxey's Sales

Market Insights Snapshot

Mr. Moxey's Historical Sales by Category

In July 2026, Mr. Moxey's consolidated 99.93% of brand sales in Edible, with Capsules reduced to 0.07% share; Edible posted 1.40% year-over-year growth and 0.91% month-over-month lift, while Capsules declined 48.68% YoY and 41.82% MoM. Overall brand sales were up 1.32% YoY despite a 16.55% decline over 24 months, and the average price moved just 0.14% YoY to $17.81, indicating the mix shift toward Edible is the primary driver of stability rather than pricing. The pattern implies a deliberate narrowing around Edible that offsets long-horizon contraction by leaning into a category where the brand retains momentum.

Within Edible, Mr. Moxey's held rank 11 in Colorado, suggesting mid-tier visibility that can be improved by compounding small monthly gains like the 0.91% MoM alongside the 1.40% YoY rise. With Capsules shrinking 48.68% YoY and contributing just 0.07% share, the portfolio effectively functions as a single-category strategy, meaning incremental share capture in Edible has disproportionate impact versus attempting to rehabilitate Capsules. The implication is to position the brand as an Edible specialist in priority markets, using modest price stability (0.14% YoY change) to protect rank while pursuing efficiency moves that convert month-level gains into rank advances from 11.

Jul-2026 Rank
Edible
11
26
18
16
Category
Share of Sales
Avg Item Price
YoY %
MoM %
Edible
99.9%
$17.81
+1.4%
+0.9%
Capsules
0.1%
$17.00
-48.7%
-41.8%
Mr. Moxey's

Competitive Landscape

Mr. Moxey's sits at rank #11 in Colorado Edible for July 2026, improving 1 position from #12 year over year and 3 positions from #14 in April 2026, while remaining 1 spot shy of its peak #10 last reached in August 2025; in comparison, Wyld held at #1 year over year despite a 24.4% sales decline and Wana slid from #2 to #3 with a 16.2% sales drop, indicating that Mr. Moxey's incremental rank gains are occurring amid top-tier softness that could widen entry into the top 10 if momentum continues.

Mr. Moxey's market ranking for CO Edible

Mr. Moxey's

Notable Products

The steepest decline came from CBC/THC 1:1 Energize Peppermint Mints 20-Pack (100mg CBC, 100mg THC), which fell 36.1% and slid to rank 9, while CBD/THC 1:1 Balance Peppermint Mints 20-Pack (100mg CBD, 100mg THC) dropped 12.7% at rank 3. In contrast, CBG/CBC/THC 1:1:1 Energize Peppermint Mints 20-Pack (100mg CBG, 100mg CBC, 100mg THC) jumped 29.8% at rank 7 and CBG/CBD/THC 1:1:1 Relief Lemon Ginger Mints 20-Pack (100mg CBG, 100mg CBD, 100mg THC) rose 9.1% to hold rank 1. With eight of the top ten being Edible mints and Energize-family SKUs diverging sharply between +29.8% and -36.1%, the mix points to a pivot toward multi-cannabinoid formulations that concentrate demand at the top while pruning weaker single-ratio Energize variants.

Product
Category
Mar-2026
Apr-2026
May-2026
Jun-2026
Jul-2026
MoM %
CBG/CBD/THC 1:1:1 Relief Lemon Ginger Mints 20-Pack (100mg CBG, 100mg CBD, 100mg THC)
Edible
2
1
1
2
1
+9.1%
Energizing Peppermint Mints 20-Pack (100mg)
Edible
1
4
2
1
2
-4.3%
CBD/THC 1:1 Balance Peppermint Mints 20-Pack (100mg CBD, 100mg THC)
Edible
3
2
3
3
3
-12.7%
CBN/CBD/THC 1:1:1 Dream Lavender Mints 20-Pack (100mg CBN, 100mg CBD, 100mg THC)
Edible
5
5
5
4
4
+6.6%
CBD/THC/CBN 2:1:1 Dream Lavender Mints 20-Pack (100mg CBD, 50mg THC, 50mg CBN)
Edible
9
9
9
7
5
+16.8%
CBD/THC 25:1 Zen Peppermint Mint 20-Pack (500mg CBD, 20mg THC)
Edible
8
8
8
6
6
-2.1%
CBG/CBC/THC 1:1:1 Energize Peppermint Mints 20-Pack (100mg CBG, 100mg CBC, 100mg THC)
Edible
>10
>10
>10
8
7
+29.8%
Relax Cinnamon Mints 20-Pack (100mg)
Edible
10
10
10
>10
8
CBC/THC 1:1 Energize Peppermint Mints 20-Pack (100mg CBC, 100mg THC)
Edible
4
3
4
5
9
-36.1%
CBD/THC 3:1 Relax Vanilla Peppermints 20-Pack (300mg CBD, 100mg THC)
Edible
>10
>10
>10
>10
10
View product & sales data

Top Selling Cannabis Brands

Simple, transparent pricing that grows with you.
Research the top cannabis brands across markets in the US and Canada.

Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.

Header image
User rating
start Today
Stay ahead of the competition with real-time market data insights.

Discover How Your Brand Stacks Up in the Market